Joshua Brumm
Chairman at Amphista Therapeutics Ltd.
Net worth: 849 960 $ as of 2024-06-29
Joshua Brumm active positions
| Companies | Position | Start | End |
|---|---|---|---|
Amphista Therapeutics Ltd.
 Amphista Therapeutics Ltd. BiotechnologyHealth Technology Amphista Therapeutics Ltd. is a biopharmaceutical company based in Biocity Glasgow, UK. The British company is focused on creating first-in-class therapeutics that selectively and efficiently degrade and remove disease-causing proteins using targeted protein degradation (TPD). The company's pipeline of novel small molecules is focused on challenging diseases, including cancer. Amphista is a spin-out of Professor Alessio Ciulli's labs at the University of Dundee and is funded by leading life science investors, including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and Biomotiv. The CEO of the company is Nicola Thompson. | Chairman | 2021-09-20 | - |
| Independent Dir/Board Member | 2021-09-20 | - | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - | - |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Private Equity Investor | 2024-05-31 | - |
Career history of Joshua Brumm
Former positions of Joshua Brumm
| Companies | Position | Start | End |
|---|---|---|---|
| DYNE THERAPEUTICS, INC. | Director/Board Member | 2019-09-30 | 2024-03-24 |
| Chief Executive Officer | 2019-09-30 | 2024-03-24 | |
| President | 2019-09-30 | 2024-03-24 | |
| Corporate Secretary | 2019-09-30 | 2024-03-24 | |
| KALEIDO BIOSCIENCES, INC. | Chief Operating Officer | 2018-07-31 | 2019-10-10 |
| Director of Finance/CFO | 2018-07-31 | 2019-10-10 | |
| ARAVIVE, INC. | Chief Operating Officer | 2013-10-31 | 2017-12-30 |
| Director of Finance/CFO | 2013-10-31 | 2017-12-30 | |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Chief Operating Officer | 2017-01-26 | 2017-11-30 |
| Director of Finance/CFO | 2014-01-06 | 2017-11-30 | |
| Public Communications Contact | - | 2017-11-30 | |
| PHARMACYCLICS, INC. | Comptroller/Controller/Auditor | 2012-10-24 | 2013-08-13 |
| Director of Finance/CFO | 2012-10-24 | 2013-08-13 | |
| ZELTIQ AESTHETICS INC | Director of Finance/CFO | 2009-11-30 | 2012-08-07 |
| Investor Relations Contact | 2011-11-27 | 2012-08-07 | |
| Public Communications Contact | 2011-11-27 | 2012-08-07 | |
| Corporate Officer/Principal | 2011-07-17 | 2011-11-27 | |
| Sales & Marketing | 2011-02-28 | 2011-07-17 | |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Joshua Brumm
| University of Notre Dame | Undergraduate Degree |
Statistics
International
| United States | 11 |
| United Kingdom | 2 |
| Germany | 2 |
Operational
| Director of Finance/CFO | 6 |
| Chief Operating Officer | 3 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 9 |
| Finance | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| DYNE THERAPEUTICS, INC. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Private companies | 8 |
|---|---|
ZELTIQ Aesthetics, Inc.
 ZELTIQ Aesthetics, Inc. Medical SpecialtiesHealth Technology ZELTIQ Aesthetics, Inc. is a medical technology company, which focuses on developing and commercializing products. Its product, the coolsculpting system is designed to selectively reduce stubborn fat bulges. The company was founded by Mitchell E. Levinson in 2005 and is headquartered in North Chicago, IL. | Health Technology |
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Amphista Therapeutics Ltd.
Amphista Therapeutics Ltd. BiotechnologyHealth Technology Amphista Therapeutics Ltd. is a biopharmaceutical company based in Biocity Glasgow, UK. The British company is focused on creating first-in-class therapeutics that selectively and efficiently degrade and remove disease-causing proteins using targeted protein degradation (TPD). The company's pipeline of novel small molecules is focused on challenging diseases, including cancer. Amphista is a spin-out of Professor Alessio Ciulli's labs at the University of Dundee and is funded by leading life science investors, including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and Biomotiv. The CEO of the company is Nicola Thompson. | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Water Street Solutions, Inc.
 Water Street Solutions, Inc. Water UtilitiesUtilities Part of Advanced Water Recovery, Water Street Solutions, Inc. provides industrial water and wastewater treatment systems and services. The company is based in Peoria, IL. Water Street Solutions was acquired by Advanced Water Recovery on February 01, 2014. | Utilities |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Finance |
- Stock Market
- Insiders
- Joshua Brumm
- Experience
